Cardiofaciocutaneous syndrome, often called CFC syndrome, is a rare genetic condition that affects the heart, facial features, and skin. It is part of a family of conditions known as RASopathies, which are caused by changes in genes that control cell growth and division. CFC syndrome is present from birth, though it may take time to diagnose because its features can vary widely from person to person.
What Is CFC Syndrome?
CFC syndrome is a genetic disorder caused by a mutation in one of several specific genes. These genes are part of the RAS-MAPK signaling pathway, a chain of proteins inside cells that tells them when to grow, divide, and mature. When this pathway is disrupted, it affects how organs and tissues develop before birth and throughout childhood.
The condition was first described in 1986 by doctors who noticed a pattern of heart defects, distinctive facial features, and skin abnormalities in their patients. It is considered a rare disease, affecting an estimated 1 in 200,000 to 1 in 300,000 people worldwide. Because it is so rare, many doctors may never encounter a case in their entire career.
CFC syndrome is not caused by anything a parent did or did not do. The gene changes happen randomly, usually with no family history of the condition. Most cases arise from new mutations that occur spontaneously in the egg or sperm before conception.
What Causes CFC Syndrome?
CFC syndrome is caused by mutations in four main genes: BRAF, MAP2K1, MAP2K2, and KRAS. These genes provide instructions for making proteins that are part of the RAS-MAPK signaling pathway. This pathway is essential for normal development, especially of the heart, skin, and facial structures.
About 75 percent of CFC cases are caused by mutations in the BRAF gene. The MAP2K1 and MAP2K2 genes account for roughly 25 percent of cases. KRAS mutations are rare, causing less than 5 percent of cases. In a small number of people with clinical features of CFC syndrome, no mutation in these known genes is found, suggesting that other unidentified genes may also be involved.
In nearly all cases, the mutation is a de novo mutation, meaning it appears for the first time in the affected person and was not inherited from either parent. The risk of a parent having another child with CFC syndrome is very low, usually less than 1 percent, unless one parent carries the mutation in their germ cells without showing symptoms themselves.
What Are the Main Features of CFC Syndrome?
The features of CFC syndrome fall into three main categories: heart, facial, and skin. However, the condition affects many other parts of the body as well. No two people with CFC syndrome are exactly alike, even within the same family.
Heart Features
Heart defects are present in about 75 percent of people with CFC syndrome. The most common heart problems include pulmonary valve stenosis, which is a narrowing of the valve that controls blood flow from the heart to the lungs, and atrial septal defects, which are holes in the wall between the upper chambers of the heart. Some people also have hypertrophic cardiomyopathy, a condition where the heart muscle becomes abnormally thick.
Facial Features
People with CFC syndrome often have distinctive facial features that become more noticeable with age. These include a high forehead, widely spaced eyes, a short nose with a broad base, and a prominent or deep philtrum, which is the groove between the nose and upper lip. The ears may be low-set or rotated backward. The face may appear coarse or rough, and some individuals have sparse or absent eyebrows and eyelashes.
Skin Features
Skin findings are nearly universal in CFC syndrome. The most common is keratosis pilaris, a condition where small rough bumps appear on the skin, typically on the arms, legs, and cheeks. Many people also have eczema, which causes dry, itchy, inflamed patches of skin. Other skin findings include thick, scaly patches on the palms and soles, and dark spots similar to café-au-lait spots seen in other genetic conditions. Some people have very curly or sparse hair, and the hair may be unusually brittle.
Other Common Features
Developmental delay is present in nearly all people with CFC syndrome. The degree of intellectual disability varies widely, ranging from mild to severe. Most children with CFC syndrome experience feeding difficulties in infancy, often due to poor muscle tone and difficulty coordinating swallowing. Growth is typically slow, and many children are shorter than their peers.
Seizures occur in about half of affected individuals. Some people have vision problems such as strabismus, where the eyes do not align properly, or nystagmus, which is involuntary eye movement. Hearing loss is less common but can occur.
How Is CFC Syndrome Diagnosed?
Diagnosis begins with a clinical evaluation by a medical geneticist who examines the heart, facial features, and skin for characteristic findings. The diagnosis is then confirmed with genetic testing. A blood sample is taken and analyzed for mutations in the BRAF, MAP2K1, MAP2K2, and KRAS genes.
Genetic testing can identify a mutation in about 90 percent of people who meet the clinical criteria for CFC syndrome. In the remaining 10 percent, the clinical features are present, but no mutation is found in the known genes. In these cases, the diagnosis remains clinical, based on the pattern of physical findings.
Because the features of CFC syndrome overlap with other RASopathies, including Noonan syndrome and Costello syndrome, genetic testing is important to distinguish between these conditions. The distinction matters because the long-term outlook and specific medical needs differ between them.
What Is the Outlook for Someone with CFC Syndrome?
The outlook for people with CFC syndrome varies significantly based on the severity of heart defects, the degree of developmental delay, and the presence of other medical complications. Life expectancy is reduced compared to the general population, but many people with CFC syndrome live into adulthood.
The most significant factor affecting survival is the severity of heart disease. People with complex heart defects or severe hypertrophic cardiomyopathy face higher risks. Those with milder heart involvement and no life-threatening complications generally have a better outlook.
Most children with CFC syndrome require ongoing support from a team of specialists. This team typically includes a cardiologist, neurologist, dermatologist, developmental pediatrician, and physical and speech therapists. Early intervention services, including physical therapy, occupational therapy, and speech therapy, can help children reach their developmental potential.
Feeding difficulties often improve with age, though some children may require a feeding tube for a period of time. Growth typically remains below average, but most individuals eventually achieve normal puberty. Adults with CFC syndrome often need continued support with daily living tasks, though some achieve independent living with assistance.
What Treatments Are Available for CFC Syndrome?
There is no cure for CFC syndrome at this time. Treatment focuses on managing individual symptoms and preventing complications. This approach is called supportive care, and it is tailored to each person’s specific needs.
Heart defects may require medication or surgery. Pulmonary valve stenosis can often be treated with a procedure called balloon valvuloplasty, where a catheter with a balloon is threaded to the heart and inflated to widen the narrowed valve. Atrial septal defects may be closed surgically or with a device inserted through a catheter. Hypertrophic cardiomyopathy is managed with medications that help the heart muscle relax and may require monitoring by a cardiologist throughout life.
Seizures are treated with anti-seizure medications. The choice of medication depends on the seizure type, and some people may need to try several medications before finding one that works. Skin conditions are managed with moisturizers, topical corticosteroids for eczema, and keratolytic agents for keratosis pilaris.
Developmental support is the cornerstone of care. Early intervention programs that begin in infancy can make a meaningful difference in motor skills, communication, and social development. Special education services and vocational training help older children and adults build skills for daily living and employment.
Can CFC Syndrome Be Prevented?
CFC syndrome cannot be prevented. Because most cases arise from spontaneous new mutations, there is no known way to reduce the risk of having a child with the condition. Genetic counseling is recommended for families who have a child with CFC syndrome to discuss recurrence risks and reproductive options.
For families who know they carry a CFC-causing mutation, prenatal testing is available. This may include chorionic villus sampling or amniocentesis during pregnancy, or preimplantation genetic diagnosis with in vitro fertilization. These options are personal decisions that families make with the guidance of their genetic counselor and medical team.
Frequently Asked Questions
Is CFC syndrome inherited from parents?
In nearly all cases, no. The gene mutation happens randomly and was not inherited from either parent.
What is the life expectancy for someone with CFC syndrome?
Life expectancy varies widely and depends mainly on the severity of heart defects and other medical complications.
Can people with CFC syndrome live independently?
Some adults with CFC syndrome achieve partial independence with support, though most require ongoing help with daily tasks.
Is CFC syndrome the same as Noonan syndrome?
No. They are related conditions in the same family, but they are caused by different genes and have distinct features.

